Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2026Journal of Drug Delivery and TherapeuticsOpen Access

Nanocarrier Platforms in Cancer Therapeutics: Design, Advances and Clinical Translation Challenges

View Full Paper
Ask AI
Bookmark
Share

Authors

STShalu TiwariAOAbhijeet OjhaASArun Kumar Singh

Discussion

Loading...

Member takes

Overview

Review demonstrates enhanced drug delivery and reduced toxicity of nanocarriers in cancer therapeutics, highlighting remaining hurdles for successful clinical translation.

Key Points

  • To examine the development, therapeutic advantages, and translation challenges of nanocarrier delivery systems in targeted cancer treatment.
  • Synthesized literature on colloidal drug delivery platforms, focusing on microemulsions, vesicular systems such as liposomes, and nanoparticle-based carriers.
  • Evaluated functional mechanisms designed to bypass biological barriers and resolve limitations of standard chemotherapy, including non-specific toxicity and rapid clearance.
  • Nanocarrier systems improve tumor penetration and retention relative to conventional antitumor drug formulations.
  • Colloidal platforms like liposomes and microemulsions reduce off-target damage to healthy cells by facilitating targeted localization and controlled drug release.
  • Therapeutic development faces continuing biological and technical barriers that must be addressed to achieve effective clinical translation.

Cite This Study

Tiwari et al. (2026) studied this question.

synapsesocial.com/papers/6aabb68c5f706d05830e5067https://doi.org/10.22270/jddt.v16i9.7852
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nanocarrier-Based Strategies for Advanced Cancer Drug Delivery and Therapeutics: Design Principles, Biological Interactions, and Clinical Potential2026 · 12 citations
  2. 2Advanced Nanocarriers for Cancer Therapies: Recent Developments and Clinical Challenges2026
  3. 3NANOCARRIER-BASED APPROACHES FOR ENHANCED ANTICANCER DRUG DELIVERY2026
  4. 4NANOTECHNOLOGY-ENABLED TARGETED DRUG DELIVERY SYSTEMS FOR PRECISION CANCER THERAPY: ADVANCES, CHALLENGES, AND CLINICAL TRANSLATION2026
  5. 5Nanotechnology in Cancer Therapy: How Nanoparticles Are Shaping the Future of Personalized Treatment2026 · 9 citations